Eco Animal Health Group Plc - Asset Resilience Ratio
Eco Animal Health Group Plc (EAH) has an Asset Resilience Ratio of -0.20% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check EAH capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1994–2022)
This chart shows how Eco Animal Health Group Plc's Asset Resilience Ratio has changed over time. See Eco Animal Health Group Plc (EAH) net asset quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Eco Animal Health Group Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Eco Animal Health Group Plc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-227.00K | -0.2% |
| Total Liquid Assets | GBX-227.00K | -0.20% |
Asset Resilience Insights
- Limited Liquidity: Eco Animal Health Group Plc maintains only -0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Eco Animal Health Group Plc Industry Peers by Asset Resilience Ratio
Compare Eco Animal Health Group Plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
ZhuZhou QianJin Pharmaceutical Co Ltd
SHG:600479 |
Drug Manufacturers - Specialty & Generic | 0.03% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
Annual Asset Resilience Ratio for Eco Animal Health Group Plc (1994–2022)
The table below shows the annual Asset Resilience Ratio data for Eco Animal Health Group Plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-03-31 | -0.20% | GBX-227.00K ≈ $-27.62 |
GBX113.60 Million ≈ $13.82K |
+0.06pp |
| 2021-03-31 | -0.26% | GBX-305.00K ≈ $-37.11 |
GBX116.89 Million ≈ $14.22K |
+0.04pp |
| 2020-03-31 | -0.31% | GBX-305.00K ≈ $-37.11 |
GBX99.99 Million ≈ $12.17K |
-0.08pp |
| 2012-03-31 | -0.22% | GBX-155.00K ≈ $-18.86 |
GBX70.02 Million ≈ $8.52K |
-4.38pp |
| 2001-03-31 | 4.16% | GBX1.11 Million ≈ $134.81 |
GBX26.64 Million ≈ $3.24K |
-2.50pp |
| 2000-03-31 | 6.66% | GBX1.58 Million ≈ $192.61 |
GBX23.77 Million ≈ $2.89K |
+2.68pp |
| 1999-03-31 | 3.98% | GBX870.00K ≈ $105.85 |
GBX21.83 Million ≈ $2.66K |
-1.17pp |
| 1998-03-31 | 5.16% | GBX852.00K ≈ $103.66 |
GBX16.52 Million ≈ $2.01K |
-1.23pp |
| 1997-03-31 | 6.39% | GBX1.01 Million ≈ $123.25 |
GBX15.86 Million ≈ $1.93K |
-3.42pp |
| 1996-03-31 | 9.81% | GBX1.19 Million ≈ $144.18 |
GBX12.08 Million ≈ $1.47K |
-11.47pp |
| 1995-03-31 | 21.28% | GBX2.59 Million ≈ $314.64 |
GBX12.15 Million ≈ $1.48K |
-15.64pp |
| 1994-03-31 | 36.92% | GBX3.90 Million ≈ $473.91 |
GBX10.55 Million ≈ $1.28K |
-- |
About Eco Animal Health Group Plc
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatm… Read more